SCHEMBL1878452

SCHEMBL1878452

CCOC(=O)C(C)CC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 1/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 2/20 0.39
ALOX15 P16050 2/20 0.39
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
SOAT1 P35610 1/20 0.39
CYP2D6 P10635 1/20 0.38
EGLN1 Q9GZT9 1/20 0.38
PIN1 Q13526 1/20 0.37
CHRM1 P11229 1/20 0.37
ADORA1 P30542 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28739690 1.00 ALDH1A1 (0.42) ALDH1A1HSD17B10MEN1NPC1KMT2A
Ethane SCHEMBL18036623 0.98 ALDH1A1 (0.40) ALDH1A1HSD17B10MEN1NPC1KMT2A
SCHEMBL9674559 0.83 ALDH1A1 (0.43) ALDH1A1HSD17B10MEN1NPC1KMT2A
SCHEMBL7598967 0.82 HCAR2 (0.41) ALDH1A1LMNACYP2C19CHRM1HCAR2
SCHEMBL19270620 0.81 ALDH1A1 (0.46) ALDH1A1HSD17B10MEN1NPC1KMT2A
SCHEMBL13643227 0.81 GAA (0.50) ALDH1A1HSD17B10KMT2ALMNACYP3A4
SCHEMBL1245716 0.81 GAA (0.50) ALDH1A1HSD17B10KMT2ALMNACYP3A4
SCHEMBL17792657 0.81 GAA (0.50) ALDH1A1HSD17B10KMT2ALMNACYP3A4
SCHEMBL2316481 0.81 ALDH1A1 (0.46) ALDH1A1HSD17B10MEN1NPC1KMT2A
SCHEMBL1301908 0.80 EGLN1 (0.42) ALDH1A1HSD17B10MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115210310-B Compositions and methods for waste polypropylene degradation 诺弗洛普有限公司 2024-08-30 CN claimed
CN-115710538-B Self-emulsifying cleaning material and preparation method and application thereof 国网上海市电力公司 2024-01-19 CN claimed
CN-116143998-A Bio-based hydroxyl-terminated hyperbranched polyester, preparation method thereof and application thereof as plasticizer 上海交通大学 2023-05-23 CN claimed
CN-115210310-A Composition and method for waste polypropylene degradation 诺弗洛普有限公司 2022-10-18 CN claimed
US-12595433-B2 Organic phosphorus compound, preparation method therefor, and uses thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2026-04-07 US disclosed
US-12365782-B2 Compositions and methods for the degradation of waste polypropylene NOVOLOOP, INC. (US) 2025-07-22 US disclosed
CN-119842643-A Alkene reductase mutant and application thereof in synthesis of (R) -2-methyl succinic acid dimethyl ester 中国科学院天津工业生物技术研究所 2025-04-18 CN disclosed
US-20250034476-A1 ORGANIC PHOSPHORUS COMPOUND, PREPARATION METHOD THEREFOR, AND USES THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2025-01-30 US disclosed
US-12122974-B2 Organophosphorus compound, and preparation process and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2024-10-22 US disclosed
CN-115210310-B Compositions and methods for waste polypropylene degradation 诺弗洛普有限公司 2024-08-30 CN disclosed
CN-118164844-A Method for preparing methyl succinic acid by catalytic hydrogenation of itaconic acid and application thereof 中国科学院青岛生物能源与过程研究所 2024-06-11 CN disclosed
US-20240092994-A1 COMPOSITIONS AND METHODS FOR THE DEGRADATION OF WASTE POLYPROPYLENE NOVOLOOP INC (US) 2024-03-21 US disclosed
WO-2007002557-A1 NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT MERCK & CO., INC. (US) 2007-01-04 WO disclosed
US-6583305-B1 Catalysts for enantioselective hydrogenation, hydroboration or 1,4 addition of olefins, ketones and imines STUDIENGESELLSCHAFT KOHLE MBH (DE) 2003-06-24 US disclosed
EP-0912583-B1 LIGANDS FOR ASYMMETRIC CATALYSIS CHIROTECH TECHNOLOGY LTD (GB) 2002-09-11 EP disclosed
US-5936109-A A CHIRAL POSPHETANE OR BISPHOSPHETANE LIGAND FOR TRANSITION METAL-CONTAINING COMPLEXES OF HYDROGENATION AND HYDROFORMYLATION CATALYSTS; STEREOSPECIFIC CHIROTECH TECHNOLOGY LIMITED (GB) 1999-08-10 US disclosed
EP-0912583-A1 LIGANDS FOR ASYMMETRIC CATALYSIS Chirotech Technology Limited (GB) 1999-05-06 EP disclosed
WO-1998002445-A1 LIGANDS FOR ASYMMETRIC CATALYSIS CHIROTECH TECHNOLOGY LIMITED (GB) 1998-01-22 WO disclosed
US-4420500-A Composition and process for preparing transparent conducting film HITACHI, LTD. (JP) 1983-12-13 US disclosed
US-3960934-A METAL HALIDE CATALYST ROHM GMBH (DT) 1976-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12122974-B2 Organophosphorus compound, and preparation process and use thereof PON1, GK, FEN1 ALDH1A1 4712/4885HSD17B10 1413/4885MEN1 3593/4885
US-12595433-B2 Organic phosphorus compound, preparation method therefor, and uses thereof NOTUM, GC, PHOSPHO1 ALDH1A1 3489/4885HSD17B10 929/4885MEN1 2432/4885
US-20250034476-A1 ORGANIC PHOSPHORUS COMPOUND, PREPARATION METHOD THEREFOR, AND USES THEREOF SOST, NOTUM, WEE1 ALDH1A1 4028/4885HSD17B10 1895/4885MEN1 3670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.